Laroxyl (Amitriptyline Hydrochloride)

Laroxyl, a tricyclic antidepressant, is employed in several psychiatric and pain‑related conditions.

• Major depressive disorder: alleviates depressive symptoms and improves mood in adult patients.
• Neuropathic pain: reduces pain intensity and improves functional ability in peripheral neuropathy.
• Migraine prophylaxis: decreases frequency and severity of migraine attacks.
• Anxiety disorders: helps control excessive worry and associated physical symptoms.

• Amitriptyline hydrochloride blocks the reuptake of norepinephrine and serotonin, increasing their synaptic concentrations. It also antagonizes muscarinic, histamine H1, and alpha‑adrenergic receptors, contributing to its antidepressant, analgesic, and anti‑migraine effects while influencing autonomic and central nervous system activity.

Amitriptyline may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Dry mouth: reduced salivary flow causing discomfort.
• Constipation: slowed gastrointestinal motility.
• Drowsiness: sedation especially after initial dosing.
• Weight gain: increased appetite and metabolic changes.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, particularly in patients with pre‑existing heart disease.
• Seizures: heightened risk at high doses or in susceptible individuals.
• Suicidal thoughts: emergence or worsening of suicidal ideation, especially early in therapy.

Before initiating Laroxyl, clinicians should evaluate several safety aspects.

• Cardiac assessment: review history of heart disease and consider ECG monitoring.
• Suicidal risk: monitor for emergence of suicidal thoughts, particularly in young adults.
• Discontinuation: avoid abrupt cessation to reduce withdrawal symptoms.
• Elderly patients: start with low doses and watch for anticholinergic effects.
• MAO inhibitor use: ensure a minimum 14‑day washout period before starting.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Amitriptyline interacts with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors: risk of hypertensive crisis and serotonin syndrome.
• Selective serotonin reuptake inhibitors: increased serotonin levels may precipitate serotonin syndrome.
• Other tricyclic antidepressants: additive cardiotoxic and anticholinergic effects.

Moderate Interactions (Monitor Closely)

• Anticholinergic drugs: heightened anticholinergic burden may worsen dry mouth, constipation, and urinary retention.
• CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation and respiratory depression.
• Diuretics: may potentiate orthostatic hypotension.